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The ErbB2 tyrosine kinase functions as coreceptor for the neuregulin receptors ErbB3 and ErbB4 and can
participate in signaling of EGF receptor (ErbB1), interleukin receptor gp130, and G-protein coupled receptors.
ErbB2−/− mice die at midgestation because of heart malformation. Here, we report a genetic rescue of their
heart development by myocardial expression of erbB2 cDNA that allows survival of the mutants to birth. In
rescued erbB2 mutants, Schwann cells are lacking. Motoneurons form and can project to muscle, but nerves
are poorly fasciculated and disorganized. Neuromuscular junctions form, as reflected in clustering of AChR
and postsynaptic expression of the genes encoding the a-AChR, AChE, e-AChR, and the RI subunit of the
cAMP protein kinase. However, a severe loss of motoneurons on cervical and lumbar, but not on thoracic
levels occurs. Our results define the roles of Schwann cells during motoneuron and synapse development, and
reveal different survival requirements for distinct motoneuron populations.
[Key Words: Motoneuron loss; neuromuscular synapse; coreceptor; neuregulin; AChR]
Received May 17, 1999; revised version accepted August 18, 1999.
The erbB2 (c-neu, HER2) gene encodes one of the four
members of the mammalian ErbB family of receptor ty-
rosine kinases (Weiss et al. 1997; Tzahar and Yarden
1998). ErbB2 has oncogenic potential when mutated or
overexpressed, and is frequently amplified and/or over-
expressed in human carcinomas. Despite an intensive
search, no high-affinity ligand has been identified for
ErbB2. Biochemical analyses indicate that ErbB2 acts as
a coreceptor for ErbB3 and ErbB4 (Goldman et al. 1990;
Carraway and Cantley 1994) and ErbB1 (the EGF recep-
tor). ErbB2 has been implicated in signaling of interleu-
kins, and forms complexes with the gp130 subunit of the
IL-6 receptor (Qiu et al. 1998). Moreover, ErbB2 is trans-
activated on signaling of G-protein-coupled receptors
(Daub et al. 1996). Genetic evidence shows that ErbB2
participates in the transmission of signals given by neu-
regulin-1 (Burden and Yarden 1997). From the single neu-
regulin-1 gene, many different isoforms of the factor are
produced by the usage of different promoters and by al-
ternative splicing. These isoforms bind ErbB4 and/or
ErbB3, and were characterized independently as (1) a fac-
tor able to induce tyrosine phosphorylation of the ErbB2
receptor as well as growth and differentiation of epithe-
lial cells (NDF or heregulin; Holmes et al. 1992; Wen et
al. 1992); (2) a mitogen for Schwann cells (glial growth
factor; Marchionni et al. 1993); and (3) an inducer of ace-
tylcholine receptor (AChR) expression in cultured myo-
blasts (AChR inducing activity, ARIA; Falls et al. 1993).
The ErbB3 receptor resembles other receptors of the
ErbB family in general structure (Kraus et al. 1989; Plow-
man et al. 1990). However, the sequence of the ErbB3
tyrosine kinase domain diverges from the consensus ty-
rosine kinase sequence, and ErbB3 has no or only very
low tyrosine kinase activity, even in the presence of its
high-affinity ligand neuregulin-1. However, when coex-
pressed with the EGF receptor, ErbB2 or ErbB4, tyrosine
phosphorylation of ErbB3 is observed in response to li-
gands like EGF or neuregulin-1 (Lenferink et al. 1998;
Pinkas et al. 1998; Riese and Stern 1998). Biochemical
evidence thus shows that various receptors of the ErbB
family can function as coreceptors for ErbB3, which ap-
pear to provide in trans the tyrosine kinase activity nec-
essary for ErbB3 signaling. Tyrosine phosphorylation of
ErbB3 results in the generation of docking sites for sub-
strates like PI-3-kinase (Tzahar and Yarden 1998).
Mice with erbB2 null mutations die before E11 (Lee et
al. 1995). Analysis of these animals showed that ErbB2 is
required for heart morphogenesis and the development
of neural crest cells and their derivatives (Lee et al. 1995;
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Erickson et al. 1997; Britsch et al. 1998). In such mice, a
marked reduction of Schwann cell precursors that ac-
company the spinal nerves is observed at E10.5, and cra-
nial sensory and sympathetic ganglia are severely hypo-
plastic. The phenotypes in neural crest cell derivatives
are similar in erbB3, erbB2, and neuregulin-1 mutant
mice at this stage, indicating that ErbB2/ErbB3 het-
erodimers transmit the neuregulin-1 signal in neural
crest cells (Lee et al. 1995; Meyer and Birchmeier 1995;
Erickson et al. 1997; Riethmacher et al. 1997; Britsch et
al. 1998). In contrast, erbB4, erbB2, and neuregulin-1
mutant mice display similar phenotypes in the heart
ventricles, indicating that ErbB2/ErbB4 heterodimers
transmit the neuregulin-1 signal in the myocardium
(Gassmann et al. 1995; Lee et al. 1995; Meyer and Birch-
meier 1995; Erickson et al. 1997).
The functional analysis of ErbB2 was limited, as mice
with erbB2 null mutations die at midgestation (Lee et al.
1995; Erickson et al. 1997; Britsch et al. 1998). We res-
cued the mutant embryos by the expression of erbB2
cDNA under the control of the heart-specific Nkx2.5
promoter. This enabled us to analyze erbB2 function
during late developmental stages.
We demonstrate that in rescued erbB2 mutant mice,
neuromuscular junctions form, as reflected in clustering
of AChR and postsynaptic expression of the genes en-
coding the a-AChR, AChE, e-AChR, and the RI subunit
of the cAMP protein kinase. Thus, synapse formation
and maturation take place, despite the absence of
Schwann cells observed in these animals and despite the
lack of ErbB2 receptor in the muscle. However, a severe
loss of motoneurons on cervical and lumbar, but not on
thoracic levels, occurs. Our results define the roles of
Schwann cells during motoneuron and synapse develop-
ment, and reveal different survival requirements for dis-
tinct motoneuron populations.
Results
Generation of the Nkx2.5erbB2 allele
The lethality of erbB2−/− mice at E11 was attributed to
myocardial malformation (Lee et al. 1995; Erickson et al.
1997; Britsch et al. 1998). To rescue the erbB2 mutants,
we expressed erbB2 cDNA under the control of the
Nkx2.5 gene, which is expressed specifically in the myo-
cardium (Lints et al. 1993). Rat erbB2 cDNA was in-
serted into exon 1 of Nkx2.5 by homologous recombina-
tion in ES cells (Fig. 1A,B), and mutant ES cells were used
to generate mice that express the erbB2 cDNA under the
control of the Nkx2.5 promoter. Animals with one copy
of the Nkx2.5erbB2 allele did not display an overt pheno-
type and were fertile. However, erbB2−/− embryos that
carry in addition one Nkx2.5erbB2 allele survived beyond
E11 (Table 1). At E10.5, the expected Mendelian ratio of
rescued erbB2−/− was observed. Some rescued erbB2−/−
embryos were lost between E12.5 and E14.5. At E14.5
and E18.5, their frequency corresponded to 5%–6%
(Table 1). A similar reduced survival was observed pre-
viously for erbB3−/− embryos (Riethmacher et al. 1997).
At birth, rescued erbB2 mutant animals displayed an
overall size reduction, they were cyanotic, did not
breathe or move spontaneously, and their lung alveoli
did not expand, although the heart continued to beat for
some time.
We found that the Nkx2.5erbB2 allele rescues trabecu-
lation of the heart ventricle of erbB2 mutants at E10.5
(Fig. 1D). Compared with control animals, the extent of
trabeculation is moderately reduced (Fig. 1D, cf. a and b).
At E18.5, the heart of rescued erbB2 mutant embryos is
well developed, although it is smaller by ∼30%, which
corresponds to the reduced size of the entire animal. RT-
PCR analysis demonstrated that transcripts derived from
the Nkx2.5erbB2 allele are present in the heart, but not in
skeletal muscle or in brain of rescued erbB2mutant em-
bryos (Fig. 1C). Thus, expression of erbB2 cDNA under
the control of the Nkx2.5 promoter rescues heart devel-
opment in erbB2−/− mice and can allow survival of the
mutants to birth.
Essential functions of erbB2 in development
of Schwann cells and other neural crest
cell derivatives
Rescued erbB2 mutant embryos, like erbB3 mutant em-
bryos, displayed defects in the development of Schwann
cells and other neural crest cell derivatives. At early
stages (E10.5, E12.5), severe reductions in the numbers of
Schwann cell precursors were observed in the roots of
spinal nerves. Sox10 or P0-positive Schwann cell precur-
sors are lacking in distal portions of peripheral nerves,
that is, along cutaneous and intercostal nerves at E12.5
or E15.5 (Fig. 2, cf. b and c and e and f with controls in a
and d, respectively). Semithin sections through the
nerves of the brachial plexus of rescued erbB2 and in
erbB3 mutant embryos at E15.5 demonstrate a reduced
nerve diameter (Fig. 2, compare h and i with control in g);
nuclei within the nerve are rare (arrowhead in Fig. 2i). A
histologically defined layer of cells that surround nerves
was observed (arrows in Fig. 2h,i; cf. control in g), whose
identity is unclear as these cells neither express Sox10,
Po, nor Patched (not shown). Immunohistology indicated
that S100-positive cells were not detected at synapses or
in distal projections in thoracic muscle at E15.5 or E18.5
(Fig. 5, below, cf. k and l with control in j). However, at
E18.5, we observed cells associated with large nerve
bundles that display a weak S100-staining (not shown).
Dorsal root ganglia formed in rescued erbB2 mutants
and contained a normal number of cells at E12.5 (Fig. 3c).
Staining of E12.5 embryos with anti-L1 antibodies indi-
cates that the overall trajectories of cutaneous sensory
nerves are not severely altered and that these nerves proj-
ect to the skin in rescued erbB2 mutants (Fig. 3b). How-
ever, sensory cutaneous nerves are severely defascicu-
lated when compared with control embryos (Fig. 3, cf. b
with control in a). The appearance of sensory cutaneous
nerves is similar in erbB3mutants (not shown). At E14.5
and at later stages, a severe loss of sensory neurons in
dorsal root ganglia was observed on all axial levels (Fig.
3c). This is similar to the loss of sensory neurons ob-
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served in erbB3 mutants (Fig. 3, cf. c with Riethmacher
et al. 1997). In contrast, cranial and sympathetic ganglia
were hypoplastic at E10.5, that is, at the time these
structures form (cf. Lee et al. 1995; Erickson et al. 1997;
Britsch et al. 1998).
Loss of distinct motoneuron populations in rescued
erbB2 mutant mice
Motoneuron numbers were determined on different axial
levels by in situ hybridization with probes specific for
VAChT (vesicular acetylcholine transporter); VAChT is
strongly expressed in motoneurons (Naciff et al. 1997; cf.
Fig. 4a,b). At E15.5, numbers of motoneurons were com-
parable in control and mutant embryos on thoracic and
lumbar levels. Rescued erbB2 and erbB3 mutants dis-
played already moderate reductions in motoneuron
numbers in cervical segments when compared with con-
trol embryos at this stage (Fig. 4c). In contrast, at E18.5,
large proportions of motoneurons were lost on cervical
and lumbar levels, whereas motoneurons in thoracic seg-
ments were minimally affected (Fig. 4d). Thus, motoneu-
rons form, but subsequently degenerate on cervical and
lumbar axial levels.
Nerve morphology and neuromuscular synapse
formation in rescued erbB2 mutant embryos
Immunohistology with anti-L1 or anti-GAP43 antibod-
ies revealed an abnormal morphology of nerve projec-
Figure 1. Generation of the Nkx2.5erbB2 allele and its
effect on heart development in erbB2mutant mice. (A)
The targeting vector (top) contains Nkx2.5 genomic
DNA (black), rat erbB2 cDNA (yellow) fused to the
ATG in exon 1 of the Nkx2.5 gene, SV40 splice accep-
tor and donor sites (green), as well as the neomycin
resistance (neo) and thymidine kinase (tk) genes. The
Nkx2.5 gene (middle) and the targeted Nkx2.5 locus
(bottom) are depicted schematically. Exon sequences
are indicated as black boxes. The probe used for South-
ern hybridization and the predicted fragments ob-
tained after HindIII (H) and NcoI (N) digestion of ge-
nomic DNA are indicated; the predicted size of the
fragments from wild-type and Nkx2.5erbB2 alleles cor-
respond to 6 and 8 kb, respectively. (B) Southern blot
analysis of genomic DNA from ES cells after digestion
withNcoI and HindIII. (Lane 1)Nkx2.5erbB2/Nkx2.5wt;
(lane 2) wild type. (C) Analysis of rat erbB2 transcripts
that derive from the Nkx2.5erbB2 locus. (Lane 1) RT-
PCR was performed on total RNA derived from heart;
(lane 2) intercostal and diaphragm muscle; (lane 3)
muscle from fore- and hind limbs; (lane 4 ) brain; and
(lane 5) a negative control without added RNA. (M)
Marker. (D) Histological analysis of the heart from em-
bryos at E10.5 (a–c) and at E18.5 (d,e). The genotypes of
the animals are indicated; arrowheads point toward
trabecules in wild-type and rescued erbB2 mutants.
Bars, top row, 200 µm; bottom row, 800 µm.
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tions and nerve terminals in mutant embryos. We con-
centrated our analysis on motor nerves originating from
thoracic segments of the spinal cord, which are only
minimally affected by motoneuron loss in the mutants.
In wild-type E15.5 embryos, single bundles of intercostal
nerves are observed from which side branches project to
Figure 2. Lack of Schwann cells in rescued erbB2 mu-
tant and in erbB3 mutant embryos. (a–c) Whole-mount
in situ hybridization of control (a), rescued erbB2 (b), and
erbB3 mutant embryos at E12.5 with a Sox10-specific
probe. Sox10-positive Schwann cell precursors observed
along the cutaneous sensory nerves in controls (arrow)
are absent in the mutants; Sox10-positive cells are pre-
sent in dorsal root ganglia of control and mutant em-
bryos (arrowheads). Whole-mount in situ hybridization
of E15.5 thoraco-abdominal walls from control (d), res-
cued erbB2 mutant (e), and erbB3 mutant (f) embryos
with Sox10 as a probe; Sox10-positive Schwann cell pre-
cursors are observed that accompany thoracic nerves in
the control, but are absent in the mutants. (g,h) Semithin
sections through nerves of the brachial plexus of control
(g), rescued erbB2 (h), and erbB3 (i) mutant embryos.
Arrows point toward histologically well-defined cellular
layers that surround nerves in mice of all genotypes. The
arrowhead in f points toward a nucleus in the nerve of a
mutant; these are only rarely observed. Bars, (a–c) 0.5
mm; (d–f) 0.1 mm; (g–i) 50 µm.
Table 1. Viability of rescued erbB2 mutant embryos
Genotype of
parents Nkx2.5erbB2/+; erbB2+/− × Nkx2.5+/+; erbB2+/−
Genotype of
litter
Nkx2.5erbB2/+ Nkx2.5+/+
erbB2+/+ erbB2+/− erbB2−/− erbB2+/+ erbB2+/− erbB2−/−
Expected ratio 12.5% 25% 12.5% 12.5% 25% 12.5%
E10.5 3 10% 8 27% 4 13% 4 13% 8 27% 3 10% S 30
E12.5 12 16% 18 25% 9 12% 8 11% 26 36% 0 0% S 73
E14.5 15 18% 26 31% 4 5% 13 15% 27 32% 0 0% S 85
E15.5 26 16% 48 29% 8 5% 28 17% 56 34% 0 0% S 166
E16.5 21 17% 39 32% 9 7% 20 16% 33 27% 0 0% S 122
E18.5 21 18% 37 32% 7 6% 17 15% 33 29% 0 0% S 115
Analysis of genotypes of live embryos generated from intercrosses of animals that carry wild-type and mutant erbB2 and Nkx2.5erbB2
alleles. The expected Mendelian ratio (expected ratio) for the different genotypes is indicated, and the numbers and percentages of
observed live embryos at different developmental stages are shown. Genotypes were identified by PCR analysis on DNA isolated from
the yolk sac. In addition to live embryos, embryos without heartbeat or with signs of resorption were observed.
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synaptic areas at regular intervals (Fig.5a). In rescued
erbB2 mutants, and in erbB3 mutants at this stage, in-
tercostal nerves are split into several bundles that run in
parallel, and side branches are poorly fasciculated and
disorganized (Fig. 5b,c). The morphology of intercostal
nerves in mutant embryos is similar at E18.5. The
phrenic nerve in the diaphragm of rescued erbB2 and of
erbB3 mutants at E14.5 is thin and defasciculated. At
E15.5, the phrenic nerve in the diaphragm is frequently
fragmented and, at later stages, only remnants of the
nerve are detectable. This coincides with the loss of mo-
toneurons on cervical levels from which the phrenic
nerve originates. In addition, the diaphragm muscle is
notably thinned at E18.5 (not shown).
Restoration of erbB2 expression in the heart allowed
us to study the potential role of ErbB2 in neuromuscular
synaptogenesis. Neuromuscular synapses were visual-
ized by staining with rhodamine-labeled a-bungarotoxin,
which revealed that AChR clusters are formed and per-
sist in thoracic muscle of rescued erbB2 mutants and of
erbB3mutants. At E18.5, a general disorganization of the
nerves was observed that appear defasciculated (Fig. 5d–
i). Frequently, AChR clusters were detected at multiple
sites along single nerve bundles in mutants (arrowheads
in Fig. 5h,i), and the clusters were often enlarged and
nonhomogeneously stained (arrows). In addition, ectopic
AChR clusters that were not contacted by nerves were
detected in both mutants (not shown). At E15.5, the dis-
tribution of AChR clusters was similar in intercostal
muscle of rescued erbB2mutants and of erbB3mutants.
Ultrastructural analysis of synapses in intercostal
muscle of rescued erbB2mutants at E15.5 revealed close
nerve-muscle contacts; however, terminal Schwann
cells were absent (Fig. 6). Synaptic vesicle accumulations
(arrowheads in Fig. 6) and putative pre- and postsynaptic
densities were observed. In the wild type, nerve-muscle
contact sites were restricted to synaptic profiles,
whereas contact regions extending over several tens of
microns were detected in the mutant (Fig. 6). The general
morphology of nerve and synapses is similar in erbB3
mutants but, compared with rescued erbB2mutants, the
disorganization appears more pronounced (not shown).
Clustered AChR are also observed in the diaphragm at
Figure 3. Morphological appearance of sensory cutaneous
nerves and loss of sensory neurons in rescued erbB2 mutants
and in erbB3mutants. Sensory cutaneous nerves in the thoracic
body wall of control (a) and rescued erbB2 (b) mutant embryos
at E12.5 were visualized by whole-mount immunohistochem-
istry with anti-L1 antibodies. (c) Cell numbers in dorsal root
ganglia on E12.5 and neuron numbers on E14.5, E16.5, and E18.5
in control (solid bars), rescued erbB2 mutants (open bars), and
erbB3mutants (hatched bars). The sum of the numbers of cells/
neurons in L4 and L5 dorsal root ganglia were determined; wild-
type numbers at each stage were normalized to 100%, and the
numbers determined in mutant embryos are displayed as the
percentage of the wild-type numbers. Mean percentages ± S.D.
are indicated (n = 2–4 embryos in each group).
Figure 4. Loss of motoneurons on different axial levels in res-
cued erbB2 mutants and in erbB3 mutants. Sections from the
cervical spinal cord of wild-type (a) and rescued erbB2 mutant
(b) animals at E18.5 after in situ hybridization with VAChT-
specific probes. (c,d) Motoneuron numbers in cervical, thoracic,
and lumbar spinal cord segments obtained from control (solid
bars), rescued erbB2 mutants (open bars), and erbB3 mutants.
(hatched bars) at E15.5 (c) and E18.5 (d). Mean numbers of mo-
toneurons per section ± S.D. (n = 2–4 embryos in each group) are
shown. Counts of neurons were not corrected for neuron size,
and therefore the numbers of neurons determined at different
developmental stages are not strictly comparable. Bar (a,b),
50 µm.
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E15.5 in rescued erbB2 mutants and in erbB3 mutants,
and were present not only in the center of diaphragm
muscle, but also at its borders. Frequently, the nerve had
apparently withdrawn from the AChR clusters (not
shown).
We analyzed post-synaptically expressed genes in in-
tercostal and diaphragm muscles at E18.5, that is,
muscle innervated by motor nerves that derive from tho-
racic (intercostal) and from cervical (diaphragm) axial
levels. In innervated muscle, expression of a-AChR, RI-
PKA, and AChE is restricted to post-synaptic nuclei, and
induction of e-AChR is observed when synapses mature
(Witzemann et al. 1991; Imaizumi et al. 1996; Massoulie
et al. 1998). In intercostal muscles, postsynaptic expres-
sion of a-AChR, RI-PKA, AChE, and of low levels of
e-AChR were observed in rescued erbB2 mutants, in
erbB3 mutants, and in control animals (Fig. 7a–f; data
not shown). Signal intensities appeared moderately re-
duced with a-AChR, RI-PKA, and AChE probes, and
bands of expressing nuclei were broader. Occasionally,
Figure 5. Absence of terminal Schwann
cells, morphology of motor nerves, and
distribution of neuromuscular synapses in
rescued erbB2 mutants and in erbB3 mu-
tants. (a–c) Appearance of proximal nerve
branches of 5th intercostal nerves as visu-
alized anti-GAP43 antibodies in wild-type
embryos (a), rescued erbB2 (b), and in
erbB3 (c) mutants at E15.5. (d–i) Distal
projections of thoracic nerves (11th inter-
costal nerves) and associated synapses at
E18.5 (d–f) were visualized with anti-L1
antibodies (green) and rhodamine-labeled
a-bungarotoxin (red) in wild-type (d), res-
cued erbB2 (e), and erbB3 (f) mutant em-
bryos. (g–i) High magnification of synapses
associated with distal projections of tho-
racic nerves in control (g), rescued erbB2
(h), and erbB3 (i) mutant embryos at E18.5;
arrowheads point toward multiple syn-
apses associated with one nerve branch,
and arrows indicate large AChR clusters.
(j–l) Schwann cells and terminal Schwann
cells associated with distal projections of
thoracic nerves (11th intercostal nerves)
and their synapses in control (j), in rescued
erbB2 (k), and erbB3 (l) mutant embryos at
E18.5. Anti-S100 antibodies (green) and la-
beled a-bungarotoxin (red) were used to vi-
sualize Schwann cells and clustered AChR
at the synapse. Bars (a–c), 160 µm; (d–f,j–l)
100 µm; (g–i) 40 µm.
Figure 6. Ultrastructural analysis of neu-
romuscular synapses in rescued erbB2 mu-
tants. Neuromuscular synapses in intercos-
tal muscle of wild-type (a) and rescued
erbB2 mutant (b) embryos at E15.5 are
shown. In both photographs, nerve (n) is up
and muscle (mu) is down. The terminal
Schwann cell (sc) that wraps the presynap-
tic motor nerve ending in the wild-type em-
bryo has an electron-dense cytosol rich in
ribosomes. The motor nerve endings in-
wild-type and mutant embryos accumulate
synaptic vesicles (arrowheads). The synaptic region in the mutant (right end in b) exhibits synaptic extracellular matrix and postsyn-
aptic electron dense material. Note the extended contact between nerve and muscle in the mutant. Bar, 0.7 µm.
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muscle fibers that did not show restricted a-AChR ex-
pression were noted (arrowheads in Fig. 7e,f). Despite the
early withdrawal of the phrenic nerve, post-synaptic ex-
pression of a-AChR, RI-PKA, AChE, and e-AChR was
also observed in the diaphragm muscle of rescued erbB2
and of erbB3 mutants (Fig. 7g–l; data not shown). Inten-
sities of the in situ hybridization signals associated with
synaptic nuclei were significantly reduced in the dia-
phragm. Moreover, nuclei expressing these genes were
distributed in an abnormal pattern (arrowhead in Fig.
7h). However, extrasynaptic down-regulation of a-AChR
was incomplete in the diaphragm of mutant embryos,
reflecting the early withdrawal of the phrenic nerve (not
shown). In limb muscles of rescued erbB2 and erbB3mu-
tants, postsynaptic expression of a-AChR was also ap-
parent, but down-regulation of a-AChR expression was
incomplete in extra-synaptic nuclei (not shown).
Discussion
Here, we report a genetic rescue of erbB2-deficient mice
by expression of erbB2 cDNA in the myocardium, which
demonstrates that the midgestation lethality of null mu-
tants is caused by myocardial malformation. The severe
abnormality in development of Schwann cells and neural
crest cell derivatives is similar in rescued erbB2 and in
erbB3 mutants. We suggest that these cells use the
ErbB2/ErbB3 heterodimer as the neuregulin receptor. It
is interesting to note that neither the ErbB4 nor the EGF
receptors, which can provide a coreceptor function for
ErbB3 in vitro, are able to take over such a role in neural
crest cells in vivo. Biochemical evidence indicates an
additional role of ErbB2 in signaling of the EGF-receptor,
the interleukin receptor gp130, and of G-protein-coupled
receptors (Goldman et al. 1990; Daub et al. 1996; Qiu et
al. 1998). Despite many potential functions of ErbB2, res-
cued erbB2 mutants are remarkably similar to erbB3
mutants, indicating that the major physiological role of
ErbB2 during development is to provide a coreceptor
function for neuregulin receptors ErbB3 and ErbB4.
Loss of motoneuron subpopulations and of sensory
neurons in rescued erbB2mutants
A severe loss of motoneurons is observed in rescued
erbB2 and erbB3 mutants in the cervical and lumbar
spinal cord at E18.5, whereas thoracic motoneurons are
minimally affected. Thus, cervical and lumbar motoneu-
rons appear to differ from thoracic motoneurons in their
requirement for, or their sensitivity toward, trophic fac-
tors that are absent in the mutants. It is well established
that spinal motoneurons are heterogeneous and differ in
expression of genes encoding transcription factors such
as members of the Lim family (Tsuchida et al. 1994). Lim
factors determine motoneuron identity, and subdivide
motoneurons into different classes that take character-
istic paths to their targets. Differentially expressed tran-
scription factors could thus provide the molecular basis
for distinct sensitivities toward trophic factors. For in-
stance, motoneuron subpopulations express different
levels of the c-met receptor tyrosine kinase, whose ac-
tivity can affect motoneuron survival. SF/HGF, the li-
gand of c-Met, as well as a muscle-derived factor of un-
known molecular structure (CDF, ChAT development
factor) differentially promote survival of cultured moto-
neurons that derive from distinct axial levels (McMana-
man et al. 1990; Yamamoto et al. 1997). Selective loss of
motoneuron subpopulations was not reported previously
Figure 7. Postsynaptic gene expression in rescued
erbB2 mutants. Whole-mount in situ hybridization on
intercostal (a–f) or diaphragm muscle (g–l). The muscle
tissue was derived from wild-type (a,d,g,j), rescued
erbB2 (b,e,h,k), and erbB3mutants (c,f,i,l) at E18.5. The
probes used were specific for RI-PKA (a–c,g–i), a-AChR
(d–f), and e-AChR (j–l). Arrowheads in e and f point
toward muscle fibers that do not show restricted ex-
pression of a-AChR. Arrowhead in h points toward nu-
clei distant from the major branch of the phrenic nerve.
Bars (a–c), 400 µm; (d–f,g–i) 200 µm; (j–l) 100 µm.
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in mutant mice during development. However, degen-
erative motoneuron diseases in mice and man can pri-
marily affect motoneurons on particular axial levels.
This raises the intriguing possibility that related mo-
lecular mechanisms function in differential survival of
motoneurons during development and in motoneuron
diseases in the adult.
The proportion of motoneuron loss at different axial
levels is similar in rescued erbB2 mutants and in erbB3
mutants. ErbB3 is not required in a cell autonomous
manner for survival of sensory or motoneurons (Rieth-
macher et al. 1997). We suggest that erbB2 acts in a simi-
lar manner and affects motoneuron survival indirectly.
Differentiating Schwann-cells or Schwann cell precur-
sors might provide the trophic support missing in the
mutants; trophic support could be provided by soluble
factors or by direct contact between Schwann cells and
axons. Schwann cells in vitro produce various neuro-
trophic factors that might affect motoneuron survival in
vivo (Bunge 1993). Alternatively, ErbB2 and ErbB3 ex-
pressed in skeletal muscle could regulate the expression
of motoneuron survival factors. Cell type-specific abla-
tion of erbB2 in Schwann-cell precursors or skeletal
muscle will allow the determination of the source of the
neurotrophic factor(s) in the future. In rescued erbB2 or
in erbB3mutants, abnormal loss of motoneurons occurs
after E15.5 in the lumbar spinal cord. Naturally occur-
ring motoneuron loss or abnormal motoneuron loss in-
duced by experimental ablation of skeletal muscle oc-
curs between E13.5 and birth on lumbar axial levels, and
thus in an overlapping, but not identical time frame
(Grieshammer et al. 1998).
Development of Schwann cells and sensory nerves
in rescued erbB2 mutant mice
Schwann cells accompany sensory and motoneurons and
derive from the neural crest (Le Douarin 1982). In erbB2
null mutant mice, the number of Schwann-cell precur-
sors is already severely reduced at E10.5 (S. Britsch and
C. Birchmeier, unpubl.). At early stages, reduced num-
bers of Sox10-positive or P0-positive cells are detected in
portions of sensory and motor nerves close to the spinal
cord, but are absent in the periphery, for instance, along
phrenic or intercostal nerves of rescued erbB2 mutants.
Thus, the few precursor cells present do not expand, nor
do they migrate along the axons. However, a cellular
layer that surrounds nerve bundles is apparent. These
cells express neither marker (Sox10 or P0) typical for
Schwann cells, Schwann-cell precursors or neural crest
cells, nor do they express a marker for the perineurium
(patched; S. Britsch and C. Birchmeier, unpubl.). Patched
encodes a hedgehog receptor and is expressed in the em-
bryonal perineurium, whose development is in part con-
trolled by desert hedgehog produced by Schwann cells
(Parmantier et al. 1999). The observed cellular layer
might therefore correspond to an abnormal perineurium.
Alternatively, it might originate from neural crest cells
that ceased to express genes typical for the lineage. The
absence of Schwann cells in rescued erbB2 mutant em-
bryos may contribute to the abnormal morphology of
nerves, and our results are compatible with a functional
role of Schwann cells in organization and bundling of
peripheral nerves.
Despite the disorganization and severe defasciculation
of sensory nerves, the general trajectory appears similar
in control and rescued erbB2 mutants. However, we ob-
serve a severe loss of sensory neurons that starts after
E12.5 on lumbar axial levels. In contrast to the loss of
motoneurons, sensory neuron loss is not restricted to
particular axial levels, but is pronounced in all dorsal
root ganglia at E18. At earlier stages, cranio-caudal gra-
dients in the extent of degeneration are apparent. Time
course and extent of degeneration of sensory neurons are
similar in rescued erbB2 and erbB3 mutants. We have
demonstrated previously that erbB3 is not required in a
cell-autonomous manner for survival of sensory neu-
rons. We suggest that erbB2 acts in a similar manner and
affects the survival of sensory neurons indirectly.
Neuromuscular synapse formation and postsynaptic
gene expression in rescued erbB2mutants
Genetic analysis in mice has provided new insights into
the molecular control of neuromuscular synaptogenesis
(Sanes and Lichtman 1999). Neuronal agrin initiates syn-
aptogenesis, and ablation of the agrin gene results in in-
complete AChR clustering and lack of postsynaptic spe-
cialization (McMahan 1990; Gautam et al. 1996). MuSK,
a muscle-specific tyrosine kinase receptor, might func-
tion in the recognition of agrin, because MuSK−/− mice
do not form synapses. However, MuSK does not bind
agrin directly (DeChiara et al. 1996; Glass et al. 1996).
Rapsyn, a downstream cytoplasmic component, is essen-
tial for clustering of AChR and ErbB2 as well as for post-
synaptic specialization (Gautam et al. 1995; Moscoso et
al. 1995). Despite a lack of, or a severe impairment in
formation of synapses, loss of motoneurons was not re-
ported in such mutant mice. Thus, synapse formation
appears not to be essential for motoneuron survival if
axons reach their targets. Synapse formation is not suf-
ficient for motoneuron survival in rescued erbB2 and in
erbB3 mutants, as pronounced motoneuron loss is de-
tected although synapses form.
Neuregulin induces AChR expression in cultured
muscle cells, and it was postulated to induce postsynap-
tic expression of the AChR subunit genes (Missias et al.
1996; Fischbach and Rosen 1997; Fromm and Burden
1998; Rimer et al. 1998; Schaeffer et al. 1998). In accor-
dance with an important role in neuromuscular junc-
tions, neuregulin-1 and the ErbB2, ErbB3, and ErbB4 re-
ceptors are clustered at the synapses (Altiok et al. 1995;
Jo et al. 1995; Zhu et al. 1995). Changes in endplate po-
tential were reported in mice heterozygous for a neu-
regulin-1 mutation (NRGIG allele), indicating a rate-lim-
iting function of the factor in maintaining high AChR
concentrations at the endplate (Sandrock et al. 1997). We
analyzed synapse formation in rescued erbB2 and in
erbB3 mutant embryos. Despite a general disorganiza-
tion of phrenic and intercostal nerves, AChR clustering
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and postsynaptic expression of a-AChR, RI-PKA, AChE,
and e-AChR can occur. Moreover, ultrastructural spe-
cialization such as synaptic vesicle accumulations, ac-
tive zones, and postsynaptic densities were observed.
Thus, synaptogenesis is initiated, and the first steps of
synaptic maturation occur. Synapses that formed in the
rescued erbB2 and in erbB3 mutants appear at least par-
tially functional, because mutant embryos move at
E16.5, albeit less than control animals. At birth, sponta-
neous motion is not observed, although prolonged tactile
stimulation can occasionally result in trunk, but not in
limb movement. Skeletal muscle expresses erbB2,
erbB3, and erbB4, but only one of these receptors is lack-
ing in our mutants; the remaining receptors might thus
function in a redundant manner in the control of post-
synaptic gene expression. We did, however, detect ecto-
pic AChR clusters and nerve sprouting in the mutant
mice and broadening of bands of nuclei that express
these genes. This may reflect a failure of effective syn-
apse maturation due to impaired neuregulin signaling at
the synapse. However, the absence of terminal Schwann
cells might also contribute to these changes. Quantita-
tive changes in postsynaptic gene expression are pro-
nounced in the diaphragm but not in intercostal muscle,
which appears to reflect the early withdrawal of the
phrenic nerve rather than a genuine difference in the
control of postsynaptic gene expression.
Terminal Schwann cells cap the neuromuscular junc-
tion and modulate synaptic transmission, affect regen-
eration of synapses in paralyzed or partially denervated
muscle, and have been implicated in the maintenance of
the neuromuscular synapse (Balice 1996; Son et al. 1996;
Ullian and Barres 1998). Here, we demonstrate that syn-
apses are formed and are stable over several days during
intrauterine development in the absence of terminal
Schwann cells. However, their absence may contribute
to alterations in morphology of synapses, nerves, and
nerve sprouting that are observed in rescued erbB2 and
in erbB3 mutants.
Materials and methods
Construction and expression of the Nkx2.5erbB2 allele
The structure of the Nkx2.5 gene has been described (Lyons et
al. 1995). To generate the Nkx2.5erbB2 allele, a targeting vector
was constructed that fuses rat erbB2 cDNA (Bargmann et al.
1986) to the start codon of Nkx2.5 in exon 1. The inserted frag-
ment contains, in addition, SV40 splice donor and acceptor
sites, as well as a poly(A) addition sequence that derives from
the pSV2neo plasmid (Bargmann et al. 1986). For selection of ES
cells, the targeting vector also contained neomycin resistance
cassette (neo) and the thymidine kinase (tk) gene. Gene target-
ing in ES cells and the generation of mice that carry the
Nkx2.5erbB2 allele was performed as described (Meyer and Birch-
meier 1995). Routine genotyping was performed by PCR. Rat
erbB2 transcripts that derive from the Nkx2.5erbB2 allele were
identified by RT-PCR. RNA from different tissues was isolated
by the use of TRIzol and a RT-PCR kit (GIBCO-BRL). Primers
used for the amplification hybridize to the 38-nontranslated se-
quence and are located upstream and downstream of the SV40
splice site present in the transcript (Bargmann et al. 1986).
In situ hybridization, histology, immunohistochemistry,
and microscopy
Whole-mount in situ hybridization was performed as described
(Britsch et al. 1998). To allow better access of hybridization
solutions, mouse embryos at E12.5 were cut into halves and,
from E15.5 and E18.5 embryos, rib cages and attached muscles
of the thorax (intercostal, diaphragm muscles, and some asso-
ciated muscles of the abdominal wall) were dissected prior to
hybridization.
For histological analysis, mouse embryos or tissues were fixed
in 4% PFA for several days at 4°C, dehydrated, and embedded in
Technovit 7100 (Kulzer); 4- to 6-µm sections were stained with
hematoxylin/eosin or with toluidine blue. For electron micros-
copy, embryos were fixed in glutaraldehyde and embedded in
Durcupan. Ultrathin sections were then cut, contrasted with
lead citrate, and viewed on a Zeiss EM910 electron microscope.
For immunohistological analysis, the embryos were prefixed,
the diaphragms or thoracic walls were dissected, postfixed in
4% PFA, blocked with 20% goat serum (GS) in PBT (PBS/0.1%
Tween-20), and incubated with anti-GAP43, anti-L1, anti-S100
polyclonal (Daco) antibodies, or rhodamine-labeled a-bunga-
rotoxin in PBT containing 5% goat serum at 4°C overnight.
Cy2-conjugated anti-rabbit IgG (1:300; Dianova) was used as
secondary antibody. The samples were examined with a Leica
confocal microscope. Whole-mount immunhistochemistry on
E12.5 embryos was performed on embryos that were cut into
halves with polyclonal rabbit anti-L1 antibodies and peroxidase-
coupled goat anti-rabbit antibodies. Embryos were cleared in
benzyl alcohol/benzyl benzoate (1:2).
Motoneuron and sensory neuron counts
Embryos were prefixed in PFA, and appropriate segments of the
spinal cord were dissected, with the attached dorsal root ganglia
as reference points to determine the axial level. After postfix-
ation, dorsal root ganglia were removed to improve access of the
hybridization solutions, and whole-mount in situ hybridization
with a VAChT-specific probe was performed. The stained tissue
was embedded in plastic and cut into 6-µm sections. Every third
section was examined, the numbers of nuclei located in the
ventral horn that were surrounded by blue-stained cytoplasm
were counted, and the averages of nuclei per section were de-
termined. For each animal, the average numbers of motoneu-
rons were determined on different axial levels. The data dis-
played are mean numbers of the averages of several animals.
Embryos or segments containing L4 and L5 dorsal root gan-
glia were embedded in Technovit 7100 (Kulzer). Serial sections
(6 µm) through L4 and L5 dorsal ganglia were stained with to-
luidine blue and every third section was counted. In ganglia of
E14.5, E16.5, and E18.5 embryos, cells with a clear nucleus and
nucleoli were counted; in ganglia from E12.5 embryos, total cell
numbers were determined. Counts were not corrected for
double or split nucleoli.
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